TY  - GEN
AU  - Adejare, Adeboye
AU  - Abdelaouf, Kamilia
AU  - Abelian, Anush
AU  - Abioye, Amos O.
AU  - Allahham, Nour
AU  - Amin, Purnima D.
AU  - Anderson, Claire
AU  - Asempa, Tomefa E.
AU  - Ates-Alagoz, Zeynep
AU  - Awad, Atheer
TI  - Remington: the science and practice of pharmacy 
SN  - 9780128200070
U1  - 615.1 
PY  - 2021///
CY  - Philadelphia
PB  - University of the Sciences in Philadelphia
KW  - Medicina
KW  - Historia
KW  - Farmacias
KW  - Farmacéuticos
KW  - Medicamentos
KW  - Cannabis
KW  - Drogas de uso médico
KW  - Química farmacéutica
KW  - Química y farmacia
N1  - Incluye contenido; Incluye referencia bibliográfica al final de cada capítulo; SECTION 1. INTRODUCTION; 1. History of pharmacy. -; 2. Integrated approach to drug nomenclature.; SECTION 2. NATURAL PRODUCTS; 3. Botanical dietary products. -; 4. Natural products and derivatives as human drugs. -; 5. Medicinal Cannabis: an overview for health-care providers; SECTION 3. PARMACEUTICAL CHEMISTRY; 6. Pharmaceutical chemistry. -; 7. Structure-activity relationships and drug design. -; 8. Pharmaceutical profiling. -; 9. Produgs. -; 10. Fundamentals of medical radionuclides; SECTION 4. PARMACOKINETIC/PHARMACODYNAMICS; 11. The science of parmacokinetic: an overview and applications. -; 12. Principles of parmacokinetic and pharmacodynamics. -; 13. Therapeutic drug monitoring. -; 14. Model-informed drug development and discovery: an overview of current practices; SECTION 5. PHARMACEUTICS; 15. Preformulation. -; 16. Powder characterization. -; 17. Salt selection. -; 18. Physical form. -; 19. Solid oral dosage forms. -; 20. Liquid dosage forms. -; 21. Medicated topicals; SECTION 6. BIOPHARMACEUTICS; 22. Biotechnology and drugs. -; 23. Therapeutic antibody discovery. -; 24. Therapeutic antibody develpment-Remington chapter. -; 25. Gene and cell therapy. -; 26. Protein drug production and formulation.; SECTION 7. PHARMACEUTICAL MATERIALS AND DEVICES/INDUSTRIAL PHARMACY; 27. Coating of pharmaceutical dosage forms. -; 28. Ophthalmic preparations. -; 29. Parenteral preparations. -; 30. Pulmonary, Nasal, and Topical Aerosol Drug Delivery Systems. -; 31. Nanotechnology. -; 32. Pharmaceutical excipients. -; 33. Hot-melt extrusion: a versatile technology. -; 34. Process validation in pharmaceutical manufacturing; SECTION 8. TOPICS IN TRASLATIONAL RESEARCH; 35. Traslational research-from basic science to an appoved therapeutic-an overview. -; 36. Traslation of gene therapies. -; 37. Large.scale molecular profiling approaches factilitating traslational medicine: genomics, transcriptomics proteomics, and metabolomics. -; 38. Neurobiologic correlates of depression: ilustration of challenges in bench-to-bedside traslation; SECTION 9. PHARMACY PRACTICE; 39. Pharmacy and patient centered care. -; 40. Medication safety and medication error prevention. -; 41. Substance use disorders. -; 42. Global trends in pharmacy practice. -; 43. Value-based payment models involving phsrmeceutical services. -; 44. Role of the pharmacist in research. -; 45. Trends in nutrition practice. -; 46. Medication disposal. -; 47. Pharmacist use of point-of-care testing to improve access to care. -; 48. Specialty pharmacy services. -; 49. Pharmacy involvement in medical missions. -; 50. Pharmacists' role in infectious pandemics: ilustration with COVID-19; SECTION 10. PHARMACEUTICAL OUTCOMES AND POLICY; 51. Health policy and pharmacy. -; 52. Implementation and evaluation of pharmacy service. -; 53. Pharmacoepidemiology and pharmacovigilance. -; 54. Pharmacoeconomics. -; 55. Law geverning the ptractice of pharmacy. -; 56.Drug distribution system
ER  -